Literature DB >> 1206397

Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients.

K G Lloyd, H Möhler, P Heitz, G Bartholini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1206397     DOI： 10.1111/j.1471-4159.1975.tb04409.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  9 in total

1.  The effect of L-dopa and propranolol on human CSF cyclic nucleotides.

Authors:  R H Belmaker; R P Ebstein; J Biederman; R Stern; M Berman; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

2.  Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

Authors:  L M Gunne; J E Häggström
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia nigra.

Authors:  J Arnt; J Scheel-Krüger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

4.  GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.

Authors:  J Arnt; J Scheel-Krüger
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

5.  Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's disease.

Authors:  M Shibuya
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

6.  Asymmetrical lateral ventricular enlargement in Parkinson's disease.

Authors:  M M Lewis; A B Smith; M Styner; H Gu; R Poole; H Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; R B Mailman; X Huang
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

7.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

8.  Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

Authors:  E K Perry; M Curtis; D J Dick; J M Candy; J R Atack; C A Bloxham; G Blessed; A Fairbairn; B E Tomlinson; R H Perry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-05       Impact factor: 10.154

9.  Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model.

Authors:  Deyu Zheng; Xiaohua Jiang; Junpeng Zhao; Deyi Duan; Huanying Zhao; Qunyuan Xu
Journal:  Neural Plast       Date:  2013-04-29       Impact factor: 3.599
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.